Skip to content

Multicenter AIDS Cohort Study (MACS)

Multicenter AIDS Cohort Study (MACS)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00046280
Enrollment
7087
Registered
2002-09-26
Start date
1984-04-30
Completion date
2020-04-30
Last updated
2019-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

This is a comprehensive observational study of HIV infection in homosexual and bisexual men.

Detailed description

The Multicenter AIDS Cohort Study (MACS) provides important information about the changing nature of HIV-mediated disease progression, the impact of antiretroviral treatment, the nature of HIV pathogenesis, and viral and host genetic factors. This study will also assess the long-term patterns of therapy use and risk-taking behaviors. Patients will have study visits every 6 months. The visits will include interviews, specimen collection, and a physical examination.

Interventions

None listed

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV negative, or * HIV positive and no history or current use of highly active antiretroviral therapy (HAART), or * HIV positive HAART recipient with documentation of HAART initiation, no AIDS diagnosis prior to HAART initiation, and a CD4 cell count and HIV-1 RNA measurement within 6 months prior to first HAART use. * Sexual intercourse with men or at least 5 male or female partners in the 5 years prior to enrollment.

Exclusion criteria

* Injection drug use within 1 year of enrollment. * Perinatally acquired HIV infection.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026